97 Assessment of Patient's Knowledge and Its Impact on Achieving Therapeutic International Normalized Ratio Goal

Introduction: Warfarin remains the sole oral anticoagulant authorized for use in heart valve replacement surgery, despite the emergence of novel anticoagulants in clinical practice. An increasing number of clinical pharmacists are now providing instruction to patients on warfarin therapy. However, to date, limited research has been conducted to explore the relationship between a patient's anticoagulation control and their level of warfarin knowledge.